BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 14, 2017
View Archived Issues
Alyeyuba shows good preclinical results for the treatment of cutaneous leishmaniasis
Read More
Zafgen begins phase II study of ZGN-1061 in type 2 diabetes
Read More
Novel approach to develop tools for detection and monitoring of multiple neurodegenerative diseases
Read More
VAXIMM's oral T-cell immunotherapy granted orphan drug status in E.U.
Read More
Umecrine Cognition reports favorable results from phase Ib trial of GR-3027
Read More
Lef1 regulates hypothalamic neurogenesis and mediates anxiety in a wide variety of animal species
Read More
NIAID agrees to support phase I study of Geom Therapeutics' GT-1
Read More
Merger between Inspyr Therapeutics and Lewis and Clark Pharmaceuticals completed
Read More
First patient with DMD completes 15 months of treatment in Carmeseal-MD expanded access program
Read More
Preliminary phase I study of the third-generation EGFR inhibitor TAS-121 in NSCLC patients
Read More
First patient dosed in phase Ia study of OncoMed Pharmaceuticals' GITRL-Fc
Read More
Otonomy announces financial and business update
Read More
ND-L02-s0201 demonstrates efficacy in preclinical lung fibrosis models
Read More
FDA accepts for review the NDAs for binimetinib and encorafenib combination
Read More
Phase III ESSENCE study of SD-101 in epidermolysis bullosa does not meet primary endpoint
Read More
FDA grants orphan drug designation to Reata's omaveloxolone for malignant melanoma
Read More
Novel small conductance channel blockers presented by Acesion Pharma
Read More
FDA advisory committee recommends approval of Shingrix
Read More
AgeneBio wins grant to support GABA-A program for MCI due to Alzheimer's
Read More
Vanda reports phase II data on tradipitant in atopic dermatitis
Read More
Phase I results presented for resminostat/S-1 combination in pancreatic and biliary tract cancer
Read More
Alligator Bioscience enters 4-1BB research agreement with University of Navarra
Read More
FDA accepts for review sNDA for mirabegron in combination with solifenacin for overactive bladder
Read More